BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19
Point-of-care blood test detects evidence of present or past exposure in 15 minutesMar 31, 2020 FRANKLIN LAKES, N.J. MORRISVILLE, N.C., March 31, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, today announced the release of a new point-of-care... Read more